Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc., will be attending the European Conference on Interventional Oncology (ECIO 2024) in Palma de Mallorca, Spain, from April 28-May 1.

To learn more about how Immunophotonics continues to explore the ability of IP-001 to transform a routine interventional-oncology procedure into a systemic immunotherapy against cancer, don’t miss Dr. Thierry de Baere at the conference’s “Meet the PI:  upcoming research 143.1 /INJECTABLE-1” session in Auditorium 3 at 15:00 to 16:30 (Europe/Vienna time) on April 28^th.  Additionally, Dr. Uwe Martens will showcase some of our research in the “Cancer as chronic disease: 112.2/Targeting the tumoral microenvironment” session in Auditorium 2 at 8:30 to 10:00 (Europe/Vienna time).